Tonix Pharmaceuticals Holding Corp. (TNXP) Files Form 4 Insider Buying : Samuel R Saks Buys 12,500 Shares

Tonix Pharmaceuticals Holding Corp. (TNXP): Samuel R Saks , director of Tonix Pharmaceuticals Holding Corp. purchased 12,500 shares on Jun 21, 2016. The Insider buying transaction was reported by the company on Jun 29, 2016 to the Securities and Exchange Commission. The shares were purchased at $2.00 per share for a total value of $25,000.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 22, 2016, Seth Lederman (CEO) purchased 20,000 shares at $2.08 per share price.On Jun 21, 2016, Bradley Saenger (CFO) purchased 2,000 shares at $2.00 per share price.Also, On Jun 21, 2016, Samuel R Saks (director) purchased 25,000 shares at $2.00 per share price.On Jun 21, 2016, Ernest Mario (director) purchased 50,000 shares at $2.00 per share price.

Shares of Tonix Pharmaceuticals Holding Corp. (TNXP) ended Monday, Jun 27, 2016 session in red amid volatile trading. The shares closed down -0.09 points or -4.39% at $1.96 with 4,23,620 shares getting traded. Post opening the session at $2.06, the shares hit an intraday low of $1.9 and an intraday high of $2.06 and the price vacillated in this range throughout the day. The company has a market cap of $37 M and the number of outstanding shares has been calculated to be 1,88,91,264 shares. The 52-week high of Tonix Pharmaceuticals Holding Corp. is $9.8928 and the 52-week low is $1.84.

Tonix Pharmaceuticals Holding Corp. Money Flow Index Chart

Leave a Reply

Tonix Pharmaceuticals Holding Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Tonix Pharmaceuticals Holding Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.